Disease review: NSCLC(Non-Small cell lung cancer)
- 최초 등록일
- 2013.06.21
- 최종 저작일
- 2012.05
- 17페이지/ MS 파워포인트
- 가격 1,000원
목차
없음
본문내용
Staging systems for NSCLC
Anatomic staging
a determination of the location of the tumor and possible metastatic sites
Physiologic staging
an assessment of a patient`s ability to withstand various antitumor treatments
Staging systems for NSCLC
TNM International Staging System
T (tumor size)
N (regional node involvement)
M (presence or absence of distant metastasis)
<중 략>
controversial
N3 or bulky IIIA disease
CTx + RTx (TOC)
CCRTx vs. sequential Tx
Survival benefit : CCRTx !
S/E (fatigue, esophagitis, neutropenia) : CCRTx !
Management of NSCLC
Stage III NSCLC
Superior sulcus of Pancoast tumor
Arising in the lung apex and invading adjacent structures producing Pancoast syndrome : Horner’s syndrome, shoulder and/or arm pain, weakness and atrophy of muscle of hand
II or III NSCLC 와 같은 단계로 staging
치료: Neoadjuvant CTx or CCRTx (in N0 or N1 involvement)
참고 자료
Harrison’s Principles of internal medicine. 18th edition, McGraw Hill, LONGO et al.